The selective reversible S-glutathiolation of specific SERCA (sarcoplasmic/endoplasmic-reticulum Ca 2+ -ATPase) cysteine residues represents a novel physiologic pathway of NO (nitric oxide)-dependent arterial smooth muscle relaxation [Adachi, Weisbrod, Pimentel, Ying, Sharov, Schöneich and Cohen (2004) Nat. Med. 10, [1200][1201][1202][1203][1204][1205][1206][1207]. This mechanism may be impaired through the irreversible oxidation of functionally important cysteine residues as a consequence of oxidative stress and aging. To establish whether in vivo aging and in vitro oxidation by peroxynitrite result in the loss of such functionally important cysteine residues of SERCA, we have developed and optimized a quantitative method to monitor the oxidation state of the individual SERCA cysteine residues using a maleimide-based fluorescence dye, TG1 (ThioGlo ® 1), as a label for cysteine residues that have not been altered by oxidation and are not involved in disulphide bridges. A high efficiency for TG1 labelling of such residues and the chemical structure of cysteine-TG1 adducts were validated by MS analysis of model peptides, model proteins and rat skeletal muscle SERCA1. Tryptic peptides containing 18 out of a total of 24 cysteine residues were identified by HPLC-ESI (electrospray ionization)-MS/MS (tandem MS). Two cysteine residues, at positions 344 and 349, were detected in the form of an internal disulphide bridge, and another 16 were found to be labelled with TG1. Using HPLC-ESI-MS, we quantitatively mapped peroxynitrite oxidation of eight cysteine residues (positions 364, 417, 420, 498, 525, 674, 675 and 938), some of which are involved in the control of SERCA activity. Biological aging resulted in the partial modification of cysteine residues 377, 498, 525, 561, 614, 636, 674, 675, 774 and 938. Neither peroxynitrite exposure nor biological aging affected the apparent SERCA1 ATP affinity. Our data show an age-dependent loss of cysteine residues (approx. 2.8 mol of cysteine/mol of SERCA1), which may be partially responsible for the age-dependent decrease in the specific Ca 2+ -ATPase activity (by 40 %).
INTRODUCTION
SERCA (sarcoplasmic/endoplasmic-reticulum Ca 2+ -ATPase) plays a key role in the relaxation of smooth, cardiac and skeletal muscle through the transport of cytosolic Ca 2+ into the SR (sarcoplasmic reticulum) or ER (endoplasmic reticulum) [1, 2] . However, other physiological and also pathological processes are associated with an abnormal activity or expression of SERCA, such as development, cell proliferation [3] [4] [5] , apoptosis [6, 7] , Brody and Darier disease, and cancer [8] [9] [10] . Three genes coding for SERCA proteins have been identified (SERCA1, SERCA2 and SERCA3), but the mRNA in each case can undergo differential processing to produce various isoforms. For example, recent studies have identified six isoforms of SERCA3 alone, designated SERCA3a-SERCA3f [11, 12] . Expression of SERCA1 is restricted to fasttwitch skeletal muscle, while SERCA2a is only produced in cardiac and slow-twitch skeletal muscle [2] . In contrast, SERCA2b and SERCA3 are present in a large variety of tissues. An important feature of SERCA is its high sensitivity towards modification by reactive oxygen species. In arteries, physiological levels of NO (nitric oxide) cause site-specific S-glutathiolation of Cys 669 and/or Cys 674 , associated with approx. 50 % increase in activity, indicated through a series of pharmacological and mass spectrometric experiments [13] . This novel mechanism is associated with NOdependent vascular relaxation. Importantly, this effect requires the simultaneous formation of NO and superoxide (O 2 − ), suggesting the intermediacy of peroxynitrite (ONOO − ). In contrast, higher, more pathological, levels of NO or peroxynitrite cause inactivation of the enzyme [14] . Such inactivation of SERCA can be physiologically detrimental, as a reduced function of SERCA has been associated with a changed cellular response to apoptotic stimuli, and also with an increased risk of cancer [7] .
Our in vivo studies have documented that biological aging leads to oxidation and nitration of SERCA, at cysteine and tyrosine residues respectively, accompanied by partial inactivation of the protein. Predominantly for SERCA2a from aged slow-twitch skeletal muscle [15] and heart [16] , MS allowed us to identify the accumulation of 3-NT (3-nitrotyrosine) at positions 294 and 295, which are located at the lumen-membrane interface of the transmembrane helix M4, and at position 753. Quantitative analysis indicated the age-dependent accumulation of up to 4 mol of 3-NT/mol of SERCA2a, i.e. the nitration of more than 20 % of all tyrosine residues.
To date, studies investigating the effect of aging on cysteine residues in SERCA in vivo have only provided information about the average number of cysteine residues modified per molecule of protein. However, a detailed mapping of the specific cysteine residues targeted by age-dependent oxidation is of tremendous interest in view of recent studies from our laboratories showing the selective stimulation of SERCA by physiological levels of NO [13] . It is known that biological aging leads to a partial loss of NO-dependent vascular relaxation, and a molecular rationale for this phenomenon could be the age-dependent oxidation of Cys 669 and/or Cys 674 of smooth muscle SERCA2 [13] . Therefore we have designed MS experiments aimed at achieving a detailed map of SERCA cysteine residues in tissues of young and old animals. For comparison, we also exposed SERCA from young animals to oxidation by peroxynitrite in vitro. Peroxynitrite was selected as an in vitro oxidant on the bases of our earlier results showing that NO-and probably peroxynitrite-dependent modifications play an important role in the oxidative modification of SERCA in vivo [15] . In order to optimize the method with adequate amounts of protein, we have focused our attention on just one isoform (SERCA1).
EXPERIMENTAL

Animals and tissue samples
The research protocol outlined in the present paper has been approved by the University of Kansas Animal Care Facility. Young (5-6-month-old) and old (34-month-old) Fisher 344 × Brown Norway F1 hybrid rats were purchased from the National Institute of Aging, from colonies maintained at Harlan Sprague Dawley. The rats were allowed to adapt for 2 weeks after arrival in a 12 h light/12 h dark cycle and were provided with water and food ad libitum. The animals were killed by decapitation, and hindlimb skeletal muscle (fast-twitch fibres) was rapidly removed, frozen immediately in liquid nitrogen and stored at − 80
• C.
Isolation of SR
SR vesicles (light fraction) were prepared as described previously [15, 17] . SR was divided into 0.1 ml aliquots, frozen rapidly in liquid nitrogen, and stored at − 70 • C. Protein concentration was determined using the BCA (bicinchoninic acid) assay using BSA as a standard according to the manufacturer's instructions (Pierce). At no stage of SR preparation did we use any reducing agents in order to maintain the oxidation state of the protein isolated from tissue.
Reaction with peroxynitrite
Peroxynitrite was prepared by the reaction of ozone with cooled aqueous sodium azide as described previously [18] . SR (10 mg/ ml of protein) was re-suspended in a buffer containing 20 mM Na 2 HPO 4 , 20 mM NaHCO 3 and 1 mM diethylenetriaminepentaacetic acid (pH 7.4). A small volume of stock peroxynitrite was added rapidly while vortex-mixing to reach desired final concentrations of peroxynitrite up to 3 mM. For control experiments, peroxynitrite was added to the buffer 5 min before mixing with SR membranes (reverse-order-of-addition experiment).
SERCA activity assays
Total, Ca 2+ -dependent and basal ATPase activities of SERCA in SR were determined at 25
• C by the colorimetric assay of P i in the presence or absence of the calcium ionophore, A23187, as outlined in our previous paper [19] . To assess the Ca 2+ -dependence of SERCA activity, the assay was conducted in the presence of 1 mM EGTA and 0.2-4 mM CaCl 2 to achieve the desired free Ca 2+ concentrations as calculated using the CHELATOR program [20] . In all of our experiments, the measured Ca 2+ -dependent ATP hydrolysis was attributed to SERCA because the Ca 2+ -ATPase activity was inhibited completely by the addition of 20 µM thapsigargin (Sigma).
Fluorescent labelling of protein thiols
Oxidation of cysteine residues was monitored using the maleimide-based fluorescent dye TG1 {ThioGlo ® 1 or methyl-10-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-9-methoxy-3-oxo-3H-benzo-[f ]chromene-2-carboxylate}, purchased from Covalent Associates. A stock solution of TG1 (2 mM) was prepared in acetonitrile. SR samples, containing 100 µg of protein in 20 mM sodium phosphate, were incubated with 200 µM TG1 in the presence of 10 % (v/v) acetonitrile and 2 % (w/v) SDS for 30 min at 37
• C and pH 7.4 to achieve maximum labelling of SR cysteine residues, as monitored by fluorescent spectroscopy. Fluorescence emission spectra of cysteine-TG1 protein adducts (10 µg of total SR protein) were recorded in 1-ml samples using excitation and emission wavelengths of 379 and 513 nm respectively, using a Shimadzu RF5000U fluorescence spectrophotometer. Glutathione was used to calibrate the absolute amount of thiols in SERCA.
Pyridoethylation of cysteine residues
For detection of reversibly oxidized cysteine residues, SERCA gel bands obtained after SDS/4-20 % PAGE separation of TG1-labelled SR were excised and extensively washed with a buffer containing 100 mM NH 4 HCO 3 and 50 % (v/v) acetonitrile, incubated with 2 mM DTT (dithiothreitol) for 30 min at 37
• C, followed by incubation with 2 % (v/v) 4-VP (4-vinylpyridine) for 1 h at room temperature (20 • C) in the dark. 4-VP was obtained from Sigma and was freshly distilled as described previously [21] .
HPLC separation of proteins
The RP-HPLC (reversed-phase HPLC) fractionation of proteins from SR was achieved according to our previously published procedure [22] . Chromatograms were monitored by absorbance (at 280 nm) or by fluorescence detection (at excitation and emission wavelengths of 379 and 513 nm respectively).
Gel electrophoresis
Native and TG1-labelled SR samples were mixed with Tris/glycine/SDS sample buffer and loaded into ten-well 1.5-mm-thick Novex Tris/glycine gradient 4-20 % polyacrylamide gels (Invitrogen). After running gel electrophoresis at 200 V for 90 min, the gels were stained by 0.1 % Coomassie Blue R250 in ethanoic (acetic) acid/methanol/water (1:3:6, by vol.) for 1 h, and destained in ethanoic acid/methanol/water (1.5:8:10.5, by vol.) until the gel backgrounds were clear.
In-gel proteolytic digestion
Protein bands of interest were excised from the gel and digested with trypsin as described previously [22] before MS analysis.
HPLC-ESI (electrospray ionization)-MS and MS/MS (tandem MS) analysis
Tryptic peptides were separated on a RP-HPLC column (0.32 mm × 150 mm Symmetry C 18 ) at a flow rate of 8 µl/min with a linear gradient rising from 20 to 95 % (v/v) methanol in 0.08 % (v/v) aqueous methanoic (formic) acid over a period of 75 min using a Waters CapLC XE system. Peptides were eluted directly into the source of a Q-TOF2 TM mass spectrometer (Micromass) with automatic functional switching between survey MS and MS/MS modes. Peaks with an intensity of more than six counts in a single scan were selected automatically for MS/ MS analysis. Identified peptides were then quantified using the MassLinx 4.0 software (Micromass) by the integration of peaks in selected ion chromatograms obtained in additional HPLC-ESI-MS runs.
NMR measurements
1 H-NMR spectra were recorded on a Bruker Avance 500 MHz NMR spectrometer. All proton signals were measured relative to TMS (tetramethylsilane) as an external standard in a capillary tube. Stock solutions (2 mM) of TG1 in DMSO-d 6 and NAC (N-acetyl-L-cysteine) in a buffer containing 40 mM NaH 2 PO 4 (pH 7.2) in 4:1 (v/v) H 2 O/ 2 H 2 O were mixed at a 1:1 ratio and incubated for 30 min at 37
• C to obtain the TG1-NAC adduct. Aliquots (0.6 ml) were incubated at different pH for different times to mimic conditions encountered by TG1-labelled peptides during sample preparation for MS analysis. All NMR spectra were recorded at 25
Statistical analysis
Quantitative results were obtained from the data for at least three independent experiments involving material isolated from different animals. SR used in the analysis of age-dependent differences was isolated separately from the skeletal muscles of five young (5-6-month-old) and four old (34-month-old) rats.
Values are presented as means + − S.D. Significance of a difference between two means was assessed using Student's t test, calculated using a two-sample unequal variance and two-tailed distribution using Microsoft Excel XP Pro software.
RESULTS
Validation of the use of TG1 as a quantitative cysteine label for MS analysis
Model experiments were designed to identify products of cysteine labelling with TG1 [molecular mass 379.1 a.m.u. (atomic mass units)] using a double mutant of chicken CaM (calmodulin; SwissProt accession number P62149) that contains two cysteine residues at positions 34 and 110 (CaM T34C/T110C [23] ). ESI-MS of the intact reduced CaM T34C/T110C before and immediately after the reaction with TG1 detected a mass increase of 758.5 a.m.u., indicating the stoichiometric incorporation of two equivalents of TG1 (results not shown). Following derivatization, the protein was subjected to trypsin digestion either in solution or in the gel.
HPLC-ESI-MS/MS analysis of the in-solution-digested sample identified doubly charged ions, [M + 2H]
2+ , with m/z 593.76 and m/z 705.32, which correspond to the TG1 adducts of the peptides ELG 34 CVMR and HVM 110 CNLGEK respectively (an increase of + 379.1 a.m.u. on the respective cysteine residues). However, even stronger signals were detected for adducts of 18 a.m.u. greater in mass, i.e. + 397.1 a.m.u., relative to the unmodified peptide (for example, [M + 2H] 2+ with m/z 714.31 in Figure 1 (A) for the peptide HVM 110 CNLGEK). This is in accord with earlier publications [24, 25] , which reported succinimide ring hydrolysis at neutral and slightly alkaline pH. Such a hydrolytic opening of the cysteine-TG1 succinimide ring leads to product P 1 , displayed in Scheme 1. In addition to the mechanism proposed previously [24, 25] , our NMR measurements suggest some hydrolysis of the lactone ring at pH 2. This is based on 1 H-NMR experiments with a model TG1 adduct of NAC, demonstrating a timedependent downfield shift of the aromatic protons of TG1 (results not shown). The mass spectrometric analysis of both hydrolysis products shows a single peak for P 1 with = + 18 a.m.u. relative to the unmodified adduct, P 0 . Solution digestion also yielded small quantities of additional products of = − 14 and = + 4 a.m.u. relative to the expected cysteine-TG1 adduct of HVM 110 CNLGEK (m/z 698.32 and 707.33 respectively) (Figure 1A ). Again, model 1 H-NMR experiments with the TG1-NAC adduct at alkaline pH (pH 9) were performed to identify the origin of these products. The incubation of TG1-NAC at slightly alkaline pH resulted in the formation of methanol, accompanied by the loss of signal from the methyl ester protons, suggesting that these products can be represented by P 2 and P 3 respectively (Scheme 1), arising from either methyl ester hydrolysis only or methyl ester hydrolysis combined with succinimide/lactone hydrolysis.
In-gel digestion also generated significant yields of the ringopened product P 1 with = + 18 a.m.u. relative to the theoretical mass of P 0 , i.e. [M + 2H] 2+ with m/z 705.32 ( Figure 1B ). However, under these conditions, ester hydrolysis appears to be a major pathway, indicated by the dominance of the [M + 2H] 2+ ion with m/z 707.28 ( Figure 1B) . Hence, for the MS identification of TG1-labelled SERCA peptides in the in-gel digests, we searched for all possible products with peptide masses modified by + 379.1, Derivatization by TG1 has been performed under non-reducing conditions and in the presence of 2 % SDS (except lanes 2 and 3). Lanes 1 and 20, molecular-mass standards (kDa); lanes 2 and 3, intact SR (from 6-month-old rat, non-treated and non-labelled); lanes 4 and 5, reverse-order of 3 mM peroxynitrite addition control; lanes 6 and 7, 0.1 mM; lanes 8 and 9, 0.3 mM; lanes 10 and 11, 1 mM; lanes 12 and 13, 2 mM; lanes 14 and 15, 3 mM peroxynitrite respectively; lanes 16 and 17, SR from 6-month-old rat; lanes 18 and 19, SR from 34-month-old rat.
+ 383.1 and + 397.1 a.m.u., and used the major isoforms for quantitative analysis. Comparative studies therefore required processing of protein samples under identical conditions.
Incorporation of the fluorescent TG1 label into SERCA
The labelling conditions were optimized to obtain maximum yields of the fluorescent cysteine-TG1 adduct as described in the Experimental section. In SR enriched with SERCA (approx. 40 % relative to total rat skeletal muscle SR protein according to gel densitometry [14, 15] ), more than 90 % of the free protein thiols are located on SERCA [14, 26] . Our RP-HPLC analysis of rat SR with absorbance and fluorescence detection showed similar values: approx. 90 % of the fluorescence signal was located in the chromatographic SERCA peak (results not shown). Therefore, using TG1 labelling of SR, we can determine the molar content of cysteine residues in the SERCA molecule. Maximal TG1 labelling of SERCA required the presence of 2 % (w/v) SDS, which resulted in the derivatization of 85 + − 8 mol of thiol/mg of SR protein or 21 + − 2 mol of reactive cysteine/mol of SERCA1. In contrast, only three to four cysteine residues/mol of SERCA1 were labelled in the absence of SDS, in agreement with a previous study [27] . Rat SERCA1 contains 24 cysteine residues. Based on the presence of at least one functionally important disulphide bridge in SERCA1 [28] , we may conclude that we achieved essentially complete labelling of the remaining cysteine residues with TG1.
Loss of reactive cysteine residues in SERCA1 upon treatment of SR with peroxynitrite and during biological aging Exposure of SR to peroxynitrite caused a concentration-dependent decrease in the total number of TG1-reactive cysteine residues (Figure 2A ). For example, after treatment of SR with 3 mM peroxynitrite, the average number of cysteine residues/mol of SERCA1 susceptible to labelling with TG1 decreased 2.5-fold ( Figure 2B ). The decrease in the number of reactive cysteine residues was accompanied by a ∼ 90 % inactivation of SERCA ( Figure 2C ). A comparison of SR from the skeletal muscle of 6-and 34-month-old rats showed a similar decrease in the number of reactive cysteine residues in SERCA1 due to biological aging in vivo, 2.8 mol of cysteine/mol of protein ( Figure 2D ). However, in contrast with in vitro peroxynitrite inactivation, the age-dependent loss of cysteine residues was accompanied by only a ∼ 40 % SERCA inactivation (1.13 + − 0.13 compared with 1.87 + − 0.17 µmol of P i /min per mg of protein, for SERCA1 from Table 1 
HPLC-ESI-MS/MS identification of TG1-labelled cysteine residues in rat SERCA1
Theoretical mass is for cysteine-TG1 adduct with a mass gain of 379.1 a.m.u. R t , elution time of a peptide; n.f., not found. 
Figure 5 Selected mass chromatogram (A) and ESI-MS/MS spectrum (B) of [M + 2H] 2+ 918.9
Inset in (B) shows the sequence of rat SERCA1 tryptic peptide 335-352 (SLPSVETLGC 344 TSVIC 349 SDK), in which Cys 344 and Cys 349 are disulphide-bonded, with detected y"-type fragment ions.
34-compared with 6-month-old rats respectively). Treatment with peroxynitrite or labelling with TG1 did not significantly affect the electrophoretic mobility of SERCA1 (Figure 3 ), permitting us to quantitatively map reactive cysteine residues using SDS/ 4-20 % PAGE separation and in-gel digestion coupled to HPLC-ESI-MS/MS analysis.
Mapping and quantification of specific cysteine residues in SERCA
A list of all 19 cysteine-containing tryptic peptides of rat SERCA1 (Swiss-Prot accession number Q64578), ranging in length from 4-88 residues, is displayed in Table 1 . Except for four peptides ( Figure 4 ). These cysteine residues were in positions 12, We verified that TG1 labelling of SERCA1 was nearly complete by application of a double-labelling approach. After primary labelling with TG1, protein samples were reduced with DTT and alkylated by 4-VP. HPLC-ESI-MS analysis of the respective tryptic digest did not reveal any significant amounts of cysteine-4-VP (+ 105 a.m.u.) adducts for cysteine-containing peptides that had been labelled with TG1. In addition, 4-VP labelling was not detected for peptides containing cysteine residues at positions 70, 318, 670, 910, which had not been identified in tryptic digests following TG1 modification. In contrast, the peptide containing the Cys 344 -Cys 349 disulphide bond was labelled successfully with two equivalents of 4-VP. This double-labelling strategy, together with the nearly complete TG1 labelling of SERCA1 indicated by the fluorescence yields, confirmed the high sensitivity of SERCA1 cysteine residues towards TG1 in the presence of 2 % SDS. The failure to detect some cysteine residues using our ESI-MS/MS approach can therefore be attributed to poor recovery of the peptides from either the gel or the HPLC column. Indeed, three of the missing cysteine residues (70, 318 and 910) are located on transmembrane helices that are highly hydrophobic and devoid of trypsin cleavage sites. In order to test a potential effect of oxidized cysteine residues, e.g. intramolecular disulphide bridges, on protein conformation, which may affect the efficiency of SERCA1 labelling and peptide yields, we compared the effect of DTT reduction on SR samples from both young and old animals. No significant changes in the yields of TG1-labelled peptides between the respective reduced and native samples were detected, except for the peptide originally containing the Cys 344 -Cys 349 disulphide bond. For the direct comparison of SERCA from different tissue samples, e.g. young and old muscle, care was taken that samples were run on the same gel in order to minimize variations arising from sample processing, i.e. times for electrophoresis, staining/ destaining, etc. Gel bands were also processed in parallel tubes under identical conditions. Moreover, a set of internal standards was employed for the quantitative comparison of protein samples, as described below.
Internal standards for TG1 labelling and peptide recovery
For quantitative analysis, a set of internal standards was selected, consisting of seven rat SERCA1 tryptic peptides, which lack oxidation-and hydrolysis-sensitive amino acids such as cysteine, methionine, tryptophan, tyrosine, histidine and asparagine ( Table 2 ). All TG1-containing peptides were normalized to the yields of these seven standard peptides in order to account for potential variations owing to differences in the digestion yields between protein samples and peptide recovery from the gel or HPLC column, which may be a function of sequence modifications and/or conformational changes of the protein. Normalization coefficients were obtained by averaging the yields of these seven standard peptides. Statistical analysis showed that the S.D. of these normalization coefficients was usually within 15-20 %.
Loss of specific cysteine residues upon biological aging in vivo or exposure to peroxynitrite in vitro Table 3 displays the quantitative results on the relative loss of specific cysteine residues in SERCA1. Treatment with up to 3 mM peroxynitrite resulted in a statistically significant (90 % confidence limits) partial loss of six out of 16 displayed reactive cysteine residues. In contrast, biological aging resulted in a partial loss of nine cysteine residues. Five cysteine residues (525, 674, 675, 498 and 938) were modified both in vivo and in vitro; Cys 364 , Cys 417 and Cys 420 were affected only by peroxynitrite in vitro while Cys 561 , Cys 636 , Cys 614 , Cys 377 and Cys 774 were partially lost during in vivo aging. Importantly, the total losses of cysteine for peroxynitrite-treated and aging SR, calculated from the integration of the mass spectrometric data, 2.57 and 3.18 mol of cysteine/mol of SERCA, were close to the values obtained by fluorescence spectroscopy of intact TG1-labelled SERCA, 2.5 and 2.8 mol of cysteine/mol of SERCA respectively. This excellent agreement validated the quantitative mass spectrometric approach. This agreement also means that the remaining cysteine residues, which were not resolved by quantitative MS, most probably do not contribute to the measured total loss of reactive cysteine in SERCA.
Effects of biological aging and peroxynitrite on Ca 2+ and ATP affinity
For skeletal muscle SR from 5-6-month-old rats (0.6 mg/ml protein), an increase in the concentration of added Ca 2+ from 0.2 to 1.2 mM (corresponding to 0.19 µM and 0.132 mM free Ca 2+ respectively in the presence of 1 mM EGTA and other buffer components) stimulated the SERCA activity more than 20-fold, showing that the protein in the SR preparation from young rats is functionally and structurally intact ( Figures 6A and 6B ). Biological aging in vivo and treatment with peroxynitrite in vitro affected the Ca 2+ concentration-dependence in different ways. SR from 34-month-old animals exhibited ∼ 40 % lower ATPase activity compared with SR from 5-6-month-old animals at free Ca 2+ concentrations of 22 µM used for Ca 2+ -ATPase activity measurements. Importantly, the analysis of normalized curves ( Figure 6A ) does not show any significant difference in the Ca 2+ concentration for half-maximal activation (K 0.5 ∼ 2 µM under our conditions), which characterizes the apparent Ca 2+ affinity of SERCA in the E1 conformational state [1, 29] . Therefore the affinity of SERCA to Ca 2+ does not significantly change with age. However, at low Ca 2+ concentrations (below 1.16 µM), the shape of the dependence for SR from old animals is different, reflecting a lower structural and functional integrity of 'old' SERCA. An increase in the concentration of free Ca 2+ stimulated the ATPase SERCA activity only 5-fold owing to a higher relative contribution of Ca 2+ -independent (basal) ATPase activity in the SR from old compared with young animals ( Figure 6A ). Peroxynitrite produced a significant decrease in the Ca 2+ affinity ( Figure 6B ): K 0.5 changed from 2 to 10 µM, reflecting the alteration of either Ca 2+ -binding domains or domains involved in allosteric regulation of the high-affinity Ca 2+ -binding sites, as was demonstrated for phospholamban and sarcolipin [29, 30] . Analysis of the ATP dependence of Ca 2+ -ATPase activity ( Figure 6C ) did not show ageassociated differences, and no effect of peroxynitrite on the ATP affinity of rat SERCA1 (K 0.5 ∼ 1 mM in our experiments). 
DISCUSSION
The redox state of specific cysteine residues of SERCA is important for enzymatic function so that modifications of different SERCA cysteine residues may result in both inhibition and activation of the protein [13, 14, 31] . Earlier studies on the role of cysteine modifications in the regulation of SERCA activity were based on either selective labelling or site-directed mutagenesis of cysteine residues that resulted in a significant change in protein activity [13, [31] [32] [33] [34] [35] [36] . Although these approaches specifically addressed SERCA modifications of selected cysteine residues, they are not so relevant to oxidative modifications of the protein cysteine residues in vivo. Previous studies involving proteolytic mapping of SERCA and HPLC-MS analysis detected several specific cysteine-containing peptides with a mass increase fitting to sulphoxidation, nitrosation and S-glutathiolation of SERCA cysteine residues, and quantified the loss of some cysteine residues upon oxidation in vitro using reactive thiol labelling [13, 14, 33] . However, all previous studies suffered from both incomplete cysteine labelling in SERCA and the use of peptide masses only (MS1 mode), but not MS/MS, for the identification of labelled peptides. Moreover, these earlier studies did not use modification-resistant peptides as internal standards for digestion yields of cysteine-containing peptides. The approach described in the present paper overcomes these shortcomings. First, labelling of the SR with TG1 in 2 % SDS resulted in virtually complete derivatization of reduced cysteine residues of SERCA1. Secondly, in-gel processing of the protein allowed the recovery of most of the cysteine-containing peptides, and of additional peptides, which can be used to normalize the yields of the labelled peptides by quantitative HPLC-ESI-MS/MS. The quantitative analysis of the TG1-labelled sequences provides a differential display of 16 out of 20 reduced cysteine residues in SERCA1 available for oxidative modification. A quantitative mapping of the specific cysteine residues in rat skeletal muscle tissue revealed nine cysteine residues targeted by age-dependent oxidation in vivo and six cysteine residues partially lost upon peroxynitrite treatment of the SR in vitro. Importantly, quantification of total cysteine losses by HPLC-MS analysis of SERCA1 digests is in agreement with the data obtained by fluorescence spectroscopy of the intact TG1-labelled protein, validating our approach and permitting the analysis of a role for specific cysteine residues in the control of SERCA activity. A comparative analysis of individual cysteine oxidation and Ca 2+ -ATPase activity shows that not all the oxidation-sensitive cysteine residues are equally important for SERCA function. A comparison of data from Table 3 with Figure 2(C) illustrates that the peroxynitrite-dependent loss of individual cysteine residues coincides with the loss of SERCA activity only for the residues at positions 674/675 and 938. No other cysteine residue shows the characteristic lag phase correlating with protein inactivation. It is likely that some of the earlier targeted cysteine residues, i.e. at positions 525, 498, 417, 420 and 364, actually protect functionally important cysteine residues from oxidation and could be considered to be intramolecular antioxidants similar to the function ascribed to protein methionine residues [14, 37] . At present, we cannot state whether the oxidation of Cys 674 , Cys 675 or Cys 938 alone serves as a 'redox switch' for SERCA1 activity, or the loss of the protein activity is because of a combination of multiple cysteine oxidation events and/or additional modifications such as methionine oxidation and tyrosine nitration. Various mechanisms for the peroxynitrite modification of thiols have been described, which may yield nitrosothiols, nitrothiols, disulphides, and sulphenic and sulphonic acid [14, 38, 39] ; our labelling technique alone cannot specify the nature of the respective cysteine oxidation products of SERCA. Biological aging leads to a partial loss of SERCA1 activity in rat skeletal muscle ( Figure 2D) , and a molecular rationale for this phenomenon could be the age-dependent oxidation of specific cysteine residues by peroxynitrite and/or other endogenous oxidants. Interestingly, the affected residues in vivo do not completely match those targeted by peroxynitrite in vitro (Table 3) The modification of these latter residues appears not to contribute significantly to the agedependent loss of SERCA function. This observation possibly reflects the occurrence and reaction of additional oxidants in vivo. In addition, the conformation of SERCA in vitro may not be completely identical with that in vivo, a feature which may lead to some differential reaction kinetics of cysteine in vitro compared with in vivo. Moreover, not only the loss of a specific cysteine residue, but also the nature of its specific cysteine oxidation product, will determine its ultimate effect on protein function.
At present, we cannot conclude which cysteine residue is more important for the loss of SERCA1 activity observed in aging rat skeletal muscle. Our ligand-binding studies did not show significant changes in either the Ca 2+ or ATP affinity of SERCA1 in aging SR. In contrast, the inactivation of SR by peroxynitrite in vitro is accompanied by a decrease in Ca 2+ affinity ( Figure 6C ). These data, again, demonstrate that SERCA cysteine oxidation by peroxynitrite in vitro does not completely simulate the agedependent modification. We did not detect a modification of cysteine residues vicinal to the high-affinity Ca 2+ -binding sites, suggesting that the effect of cysteine oxidation on catalytic function may not be due to modification of specific ligand binding sites on the protein, but, rather, through more general effects on the protein structure, uncoupling ATP hydrolysis from Ca 2+ translocation. In support of this suggestion are our data showing that the decrease in Ca 2+ -dependent ATPase activity in aging SR results
